Houston Life Sciences Conference

Tue Feb 17, 2026

Buy Tickets Attendees

Houston Life Sciences Conference

Leaders from TMC, McCord, SanJac, BCM, and more discuss innovation, lab space, development and commercialization

Tuesday February 17 2026 @ 8:00 AM CST

$109.00

Get Tickets and Info Attendee List Get Tickets and Info Become A Speaker

Registration Questions?
**Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised.
**Bisnow is a cashless, checkless operation. Please only submit payment via credit card.

Speakers and Panels

Gabe Lerner

EVP, Lincoln Property Company

Dr. Ramanan Krishnamoorti

VP, University of Houston

Monique Knighten, PhD

Executive Director, Houston, Portal Innovations

Dr. Brenda Hellyer

Chancellor, San Jacinto College

Shawn Cloonan

Life Sciences Lead & General Counsel, McCord Development

Joseph Petrosino

Chief Scientific Innovation Officer, Baylor College of Medicine

William F. McKeon

William “Bill” McKeon is the President and Chief Executive Officer of the Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas Medical Center’s member institutions to enhance its leadership position in the life sciences. McKeon joined the Texas Medical Center in 2013 as executive vice president, chief operating officer and chief strategy officer. McKeon attended Roger Williams University on the Harold G. Way Scholarship for Leadership and Academic Excellence. He worked throughout his college years as a legal intern at Asquith, Merolla, Anderson, Ryan & Wiley – a prestigious law firm in Providence, Rhode Island. He graduated with top honors with a Bachelor of Science in Legal Studies. He earned his master’s degree from University of San Francisco School of Management. McKeon began his professional career at Du Pont de Nemours. He initially led the implementation of large news publishing systems around the world and was later promoted to run marketing and business development. During his time at Du Pont, McKeon lived throughout the United States, United Kingdom and Sweden. His career shifted to health care when he was recruited to Stanford University Medical Center, where he initially led the Cardiovascular Medicine and Cardiothoracic Surgery business. He was then promoted to Director of Market Development for all 17 business lines at Stanford. He then went to Raytel Medical Systems - the largest cardiac monitoring business in the United States. He served as Executive Director and digitized all businesses so that physicians could see patients’ EKGs online from anywhere in the world. At Raytel, he won the Computer World Smithsonian Award in Medicine. McKeon came to Houston to join U.S. Oncology, which provides cancer care for over 25 percent of the U.S. population. There, he served as Senior Vice President of Marketing and Pharmaceutical Business Relations. During McKeon’s tenure, U.S. Oncology grew from $250 million to $1.4 billion, filed for IPO and was later acquired by the McKesson Corporation. McKeon then moved to Medtronic Inc., the largest medical device company in the world. He led Strategy and Emerging Technologies across all of the Medtronic businesses. His main focus was to define the digital strategy for all Medtronic medical devices so that they could connect to cellular devices. McKeon was then recruited to serve as President and CEO of Microport Inc. in Shanghai. He grew the business from $17 million to $157 million in two years. Additionally, he diversified the business from one line to four lines and prepared the company for IPO. Today, Microport is listed on the Hong Kong stock exchange. McKeon then moved to London to serve as President and CEO of Cellnovo, the first mobile diabetes management system in the world. He raised $10 million for its Series A round and $57 million for the Series B. Cellnovo is public on the European Exchange.

Texas Medical Center

President & CEO

Keynote

William F. McKeon

President & CEO, Texas Medical Center

Why You Should Attend

Join us at the Houston Life Sciences Commercial Real Estate Conference, where researchers, developers, investors, and real estate professionals converge to examine the forces shaping one of the fastest-growing innovation hubs in the country. Houston’s world-class medical institutions, biotech startups, and research facilities are driving breakthroughs in healthcare, pharmaceuticals, and medical technology.

This event will highlight how real estate development, capital investment, and cross-sector collaboration are fueling the growth of the city’s life sciences ecosystem. From building next-generation lab and manufacturing facilities to fostering partnerships between academia and industry, attendees will gain valuable insights into the future of life sciences and its impact on commercial real estate.

We'll Cover:

Houston Life Sciences State of the Market
- Overview of the city’s life sciences momentum and its growing competitiveness with other national hubs.
- Key development corridors and projects anchoring Houston’s position as a global life sciences leader.
Biotech and Pharma: Innovations Driving Healthcare Forward
- Advances in biotechnology, pharmaceuticals, and cell/gene therapies emerging from Houston.
- How partnerships with research hospitals and startups are shaping global healthcare innovation.
Academic and Research Partnerships
- The role of institutions like the Texas Medical Center, University of Houston, and Rice University in advancing research.
- How collaborations between academia, developers, and the private sector accelerate commercialization.
Talent and Workforce Development
- Houston’s strategies for building a competitive life sciences workforce.
- Educational pipelines, workforce training, and talent attraction critical to sustaining sector growth.
MedTech and Digital Health
- How medical technology, AI, and digital health innovations are reshaping care delivery.
- Case studies of Houston companies leading advancements in telemedicine, wearable devices, and health informatics.
Capital Markets and Investment Strategies
- Financing models and investor perspectives on life sciences real estate in Houston.

Who You’ll Meet During Networking: Universities, Owners, Developers, Investors, Brokers, Lawyers, Contractors, Construction, Architects, Designers, Tenants, End Users, and investors in the Houston life sciences market, Leasing Agents, Financial Institutions, Government Officials - Biotech Executives, BioMed Executives, Pharmaceutical Executives, and Life Science Real Estate Professionals.

Why You Should Attend: Bisnow events bring together the biggest power players in the industry to identify opportunities, build your network and expand your business. With the largest audience of commercial real estate professionals in the world, no one knows how to help your business more than us. Join Bisnow as we jump into the market to analyze its strengths and strategize on its areas of opportunity. You don't want to miss this event!

Agenda

Time	Activity
8:00 AM 9:00 AM	Breakfast and Networking
9:00 AM 9:30 AM	Opening Keynote: TMC President and CEO Bill McKeon
9:30 AM 10:15 AM	Construction, Collaboration, and Innovation In the Patient and Innovation Environment Hear from The Leaders Building a Healthier Houston
10:15 AM 11:00 AM	Capital, Investment, and What Tenants Need to Succeed Developers, Investors, and Incubators on Funding the Future
11:00 AM 11:30 AM	Closing Networking

Want to get a recap of everything covered at the event?

Purchase the post-event summary and get the highlights sent to you in a post-event summary. Purchase here.

Call:	202-684-2034
Email:	eventregistration@bisnow.com